AbbVie Affirms FY2026 Adj EPS Guidance of $13.87-$14.07 vs $14.08 Est

Benzinga Newsdesk www.benzinga.com Positive 42.5%

Neg 0% Neu 0% Pos 42.5%

AbbVie (NYSE:ABBV) affirms FY2026 Adj EPS guidance from $13.87-$14.07 to $13.87-$14.07 vs $14.08 analyst estimate..

Comments

No comments yet. Be the first!